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ABSTRACT
Background. Ginger is a widely used ingredient in Southeast Asian countries and has gained
increasing popularity in the Western diet due to its purported health benefits. Ginger has high
antioxidant power because of its rich phytochemistry profile that contributes to its antiinflammatory properties. While there have been animal studies, the research of ginger’s effects
in humans is limited.
Objective. We sought to understand ginger’s effects on commonly assayed inflammatory
biomarkers—C-Reactive Protein (CRP), Interleukin-6 (IL-6), and Tumor Necrosis Factor-Alpha
(TNF- α)—in individuals with varying levels of physical activity. We propose that ginger may
lower levels of these biomarkers due to its inherent anti-inflammatory characteristics.
Design. We designed an eight-week cohort study. Blood draw measurements were taken at three
timepoints: the start of study, at week four, and upon completion of study.
Participants/setting. The study was conducted at Loma Linda University, where we enrolled
twelve participants with a mean age of 42.4 ± 11.4 years who exercised at least once/week, did
not take any anti-inflammatory medications, and who were free of any chronic inflammatory
conditions.
Intervention. Participants were instructed to take three grams of ginger supplement mixed with
lemonade powder to improve palatability daily. Participants also completed a pre- and postintervention Short Form Health questionnaire (SF-36) to evaluate quality of life.
Main outcome measures. Inflammation was measured using three blood biomarkers: CRP, TNFα, and IL-6. Quality of life was measured using the SF-36 questionnaire.
Statistical analyses performed. The three inflammatory biomarkers were analyzed using the
Friedman non-parametric test and the Wilcoxon test where appropriate. The SF-36 questionnaire
was analyzed using a paired t-test.
Results. Results of our study indicated a statistically significant reduction in TNF- α (p = .04)
and a clinically significant reduction of greater than 15% in IL-6. There was a significant
improvement in the domain of emotional well-being on the SF-36 after the ginger
supplementation (p = .05).
Conclusions. Ginger may potentially be used as an adjuvant intervention in the prevention
and management of chronic inflammatory diseases such as cardiovascular disease, diabetes, and
obesity.
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INTRODUCTION
Aging is associated with chronic low-grade inflammation, causing an increased risk of
numerous diseases, poor physical functioning, and mortality.1 When comparing circulating levels
of pro-inflammatory cytokines, such as C-reactive protein (CRP), Interleukin-6 (IL-6), and
Tumor Necrosis Factor-α (TNF-α) in youth versus the elderly, researchers found a two- to fourfold increase in these markers for the elderly, even if the older individuals did not have any
chronic disease present.1,2 This may be a result of a significant decline in immune function,
antioxidant capacity, increased oxidative stress, and circulating levels of reactive oxygen species
(ROS) during the aging process.1,2
Inflammation can be measured using various blood biomarkers, specifically CRP, IL-6, and
TNF-α. Environmental factors such as aging, obesity, diet, and smoking result in increased
inflammation, and subsequently higher levels of these blood biomarkers. 3 Sustained elevated
levels of these factors can transition to chronic inflammation, leading to more serious medical
conditions.
Elevated high sensitivity CRP (hs-CRP) analysis—a test used to detect the lower levels of
CRP associated with long-term, low-grade inflammation—supports evidence for induction of
prothrombotic pathways and atherosclerosis.4 C-reactive protein stimulates the production of
monocytes, which then produces tissue factors involved in the coagulation system.5 There is also
evidence to show that elevated CRP is linked to an increased risk of coronary artery disease,
stroke, and myocardial infarction.5
Interleukin-6 is an immune response mediator that plays a role in autoimmune and chronic
inflammatory diseases.6 When there is a local lesion or stress, IL-6 is produced, followed by
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inflammatory proteins including CRP, serum amyloid A (SAA), and others. Prolonged high
levels of IL-6 contributes to a progressive degeneration of various organs and organ systems. 6
Tumor Necrosis Factor-α, similar to IL-6 in promoting inflammation, also plays a role in
immune function. It stimulates macrophages and recruits inflammatory cells to kill various types
of infectious bacteria.7 This biomarker has additional roles such as anti-viral and anti-tumor
properties, to name a few.7 Since there is a strong association between high levels of CRP, IL-6
and TNF-α and chronic inflammation, anti-inflammatory therapy may have the potential to lower
these biomarkers and minimize damage caused by chronic inflammatory pathways.8
Besides aging, exercise is also known to impact inflammation levels. When individuals
exercise, two types of inflammatory pathways are recruited: acute and chronic inflammation.1 An
increase in acute inflammation occurs immediately after exercising and can produce short-term
discomfort, particularly for those who do not exercise regularly or have just started exercising. 1,9
Regular moderate exercise can also reduce chronic inflammation, which is among the benefits
desired for long-term health.1,8,10 For this reason, exercise is an important factor to consider in the
multi-faceted approach to the curtailment of inflammation. Exercise alleviates chronic or
systemic inflammation in regularly exercising adults over 70, but not to the same degree as in
younger individuals.8,10 Increased chronic inflammation in individuals over the age of 70 has
been hypothesized to be due to general inflammation associated with the aging process. 1,9 This
suggests that individuals over the age of 70 may not be able to alleviate acute inflammation in a
normal timeframe as compared to younger individuals.
Foods offer an ideal source of readily-available, relatively inexpensive therapeutic potential
for sustained anti-inflammatory actions. Foods with demonstrated anti-inflammatory properties
include but are not limited to citrus fruits, strawberries and other berries, and high sources of
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omega-3 fatty acids such as spinach, nuts, and fatty fish.11,12 Spices, such as ginger and
cinnamon, have also been studied for their anti-inflammatory properties.13
Conversely, foods that elevate inflammation levels include refined carbohydrates, added
sugar, and certain omega-6 fats.14 The effect is initially acute but can transition into chronic
inflammation if a diet consisting largely of these foods persists. Therefore, the ideal antiinflammatory diet would emphasize increased consumption of foods that decrease inflammatory
cytokines and decrease foods that are known to trigger inflammation. 14
Ginger (Zingiber officiale) is commonly used in Southeast Asian foods and as a remedy in
alternative medicine because of its rich phytochemical benefits.15,16 The non-volatile components
of ginger consist of gingerols, shogaols, diarylheptanoids, phenylbutenoids, flavonoids,
diterpenoids, sesquiterpenoids, paradols, and zingerone.17,18 These bioactive compounds are
found in the rhizome of the plant and have been shown to be effective in treating many medical
conditions, such as wounds, muscular pains, atherosclerosis, ulcers, and stomach discomfort. 18
The phenolic compounds in gingerols have been shown to have powerful antioxidant and antiinflammatory effects through the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2)
enzymatic pathways.19 Cyclooxygenase-1 is a pathway involved in maintaining homeostatic
function in the body and is always active at a baseline level. The role of the cyclooxygenase-2
system is to halt oxidative stress or injury and is important in regulating inflammation.19 If
unmanaged and overstimulated, the COX-2 pathway can lead to chronic inflammation over
time.19
Because ginger is a rich source of antioxidants, increasing antioxidant levels in the body
through the intake of ginger can potentially combat the higher levels of oxidative stress that
occur as a result of diet, aging, and environmental stressors. 16 This can help lower the COX-2
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pathway activity. In doing so, ginger may yield great benefits in the management of diseases
such as cardiovascular disease, immune system-related illnesses, and cancer.16
There are few studies on ginger’s anti-inflammatory effects post-exercise. The research is
rather limited and mainly focus on athletes who engage in high-intensity interval training in a
relatively young age group (20s-30s).13,20 Historically, IL-6 and hs-CRP were the markers
measured in experiments involving ginger supplementation.21,22 However, TNF-α has also been
found to play an important role in inflammation in the body. Therefore, the purpose of our
graduate student research study was to observe the effects of ginger on hs-CRP, IL-6, and TNF-α
levels in individuals of varying exercise activity levels.
METHODS AND MATERIALS
All methods and procedures were approved by Loma Linda University’s (LLU)
Institutional Review Board prior to the start of the study. We recruited 12 healthy male and
female LLU faculty, staff, family members, and friends with a mean age of 42.4 ± 11.4 years
who reported varying activity levels. Recruitment was accomplished through email and flyers
that were distributed around the LLU campus. Subjects filled out a questionnaire to provide us
with demographics.
Inclusion and exclusion criteria were outlined to obtain an unbiased and diverse sample
group for this study. The inclusion criteria stipulated that participants must be between the ages
of 30-70 years and have participated in various levels of activity outlined by the General
Physical Activities Defined by Level of Intensity by the American College of Sports Medicine
(ACSM) and the Centers for Disease Control and Prevention (CDC). Individuals were excluded
from the study if they were currently taking Aspirin (Acetylsalicylic Acid), Coumadin (Warfarin
or Jantoven), supplements containing ginger (Zingiber officinale, ginger root, black ginger,
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zingiberis rhizoma) more than one time per week within the last month, or Heparin (Hep-Pak,
Heparin Lock Flush, Hep-Pak CVC, Hep-Lock, Heparin Sodium ADD-Vantage). Individuals
with chronic inflammatory conditions such as cancer, CVD, diabetes, gastroesophageal reflux
disease (GERD), ginger allergies, metabolic syndrome, and/or autoimmune diseases such as
rheumatoid arthritis, were also excluded from participating in the study. Individuals with
phenylketonuria were also excluded due to the presence of Aspartame in the lemonade flavoring
agent.
The purpose, basic design, and the individual’s role in the study were explained to
potential participants. While there were no direct benefits to participants, the results of the study
could potentially contribute to researchers’ and clinicians' increased understanding of ginger’s
role in inflammation and its possible use as a complementary treatment modality for lowering
inflammation. Risks to participants were minimal and involved a potential breach of
confidentiality and momentary digestive discomfort. The risks involved in drawing blood
included, but were not limited to, momentary discomfort at the site of the blood draw, possible
bruising, redness, swelling around the site, bleeding at the site, feeling lightheaded when the
blood is drawn, possibly fainting, and rarely, obtaining an infection at the site of the blood draw.
If a participant fainted during or after the blood draw, the licensed phlebotomist would safely
stop the procedure and place the participant’s head between their knees. A cold compress would
then be applied to the back of the neck. Usually, this is a sufficient and effective measure in
helping a participant recover from a fainting spell. The phlebotomist would have stayed with the
patient for at least 15 minutes to make sure the participant is fully recovered. All recruited
participants signed an informed consent form before being admitted into the study.
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Once participants signed the informed consent, subjects filled out the following assessment
forms:
1) Demographics Questionnaire – Developed by the researchers to gather information about
the participants. This questionnaire included questions about height, weight, amount of
exercise, medications taken, medical conditions, and their use of ginger supplements. The
average time for completion of the questionnaire was five minutes.
2) SF-36 – 36-item Quality of Life Assessment developed by the Research and
Development (RAND) Corporation which assesses overall health. It measures eight
different dimensions including physical functioning, role limitations due to physical
health, role limitations due to emotional problems, energy/fatigue, emotional well-being,
social functioning, pain, and general health.23 The average time for completion of the
questionnaire was ten minutes. The participants filled out the survey pre- and post-study.
After participants filled out the consent and surveys, they were scheduled to come in after fasting
for 10 hours for their blood draw. A certified phlebotomist proceeded with an 8 mL blood draw
(0.5 tablespoons) to establish baseline hs-CRP, IL-6, and TNF-α levels. Test tubes were labeled
with the participants’ randomly-assigned numbers, followed by the letter “A” to signify the first
sample of the study. Before participants left, they were provided with an eight-week supply of
ginger powder (168 g total), pre-portioned Crystal Light® lemonade powder, measuring spoons,
and a compliance sheet. Starting on the day of the first blood test, participants took a 3 g powder
supplement of ginger mixed with the Crystal Light® lemonade powder and water (as desired)
with meals once a day for eight weeks. At the end of week 4 (day 6, 7, or 8), the participants
returned to Nichol Hall for another blood test to collect mid-intervention hs-CRP, IL-6, and
TNF-α. Test tubes were labeled with the participant’s ID number followed by the letter “B” to
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signify the second sample of the study. Participants continued to follow the supplement regimen.
At the end of week 8 (day 6, 7, or 8), participants returned to Nichol Hall to fill out the postintervention SF-36 survey, submit their compliance worksheet, and for their final blood draw.
Each subject that completed the 8-week study received a $5 gift card.
Inflammatory Biomarkers
Venipuncture Blood Draw
Inflammation was assessed using the biomarkers IL-6, hs-CRP, and TNF-α, extracted by
a venipuncture blood draw. Blood draws were conducted three separate times on each
participant: pre-intervention, mid-intervention, and post-intervention. On the night before each
blood test, the participant was able to take regular medications except for over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) such as Advil, Aleve, Motrin, Excedrin, Midol,
Nuprin, etc. The subjects arrived in the morning at the Clinical Molecular Laboratory in Nichol
Hall Room A117 after having fasted for 10 hours prior to the blood draw. Blood draws were
conducted by certified phlebotomist Kristin Bruhjell. Participants were seated in a comfortable
chair and venous blood was drawn from the antecubital vein using a standard venipuncture
protocol for a total of 8 mL or 0.5 tablespoons of blood.
Analysis of hs-CRP
High sensitive C-reactive protein (hs-CRP) concentrations were measured using a Point of
Care Diazyme (POC) SMART 700 | kit, according to the manufacturer's instructions. After
calibrating the POC SMART 700 instrument to the specific kit, a 20-μL sample of the whole
blood at room temperature was placed into the Diazyme Reagent System cuvette using a pipette.
The cuvette was then wiped with a non-abrasive tissue to ensure a clean surface. The sample was
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then placed into the instrument to be analyzed. Results were seen in approximately 4 minutes.
Samples were run in duplicates to reduce error.
Analysis of IL-6 and TNF-α
Whole blood serum samples were frozen until all the participants completed the study.
When all samples were collected, the samples were packaged and shipped to the Cytokine
Reference Laboratory (CRL) at the University of Minnesota. Samples were analyzed by Mr.
Michael Ehrhardt, BSc. Samples were analyzed for IL-6 & TNF-α simultaneously using the
Luminex platform and conducted as a high-sensitivity multi-plex analysis according to the
manufacturer’s instructions. In brief, fluorescent color-coded beads, pre-coated with anti-human
(IL-6, TNF-α) capture antibodies, were added. After incubation and washing, biotinylated antihuman detection antibodies were added, followed by phycoerythrin-conjugated streptavidin. The
beads were read on a Luminex instrument (Bioplex 200) which is a dual-laser, fluidics-based
instrument. One laser determines the analyte being detected via the color coding of the beads; the
other measures the magnitude of the red phycoerythrin signal from the detection antibody, which
is proportional to the amount of analyte bound to the bead. Samples were run in duplicate and
values were interpolated from 5-parameter fitted standard curves generated on each 96-well
plate.
Changes in inflammatory levels were analyzed by comparison of the mean blood marker
levels of individuals at three different time points. Significance was set at p ≤ 0.05. The three
inflammatory biomarkers were analyzed using the Friedman non-parametric test. The eight
different categories of the SF-36 questionnaire were analyzed using a paired t-test.
RESULTS
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The demographic data of all 12 participants are displayed in Table 1. Our population
consisted of an equal distribution of men and women, six per group, with ages ranging from 30
to 59 and a mean age of 42.4 ± 11.4 years. For the analysis of data, one large group was used
instead of the two proposed groups of exercisers vs. non-exercisers, due to an imbalance with
respect to both age and gender.
Nonparametric measures were used for statistical analysis of the three blood
inflammatory biomarkers: hs-CRP, IL-6, and TNF-α. The statistical tests used were the Friedman
test of differences among repeated measures and the one-way ANOVA. Each participant’s initial
inflammatory biomarker measurement served as the control.
Based on our results, hs-CRP levels did not differ over the three-time points, χ2 (2, n=12)
= 1.03, p = .60 (Table 2). Interleukin-6 was not significantly different over the three-time points,
χ2 (2, N=12) = 3.30, p = .19 (Table 2). Tumor Necrosis Factor-α levels over the three-time points
were significantly different, χ2 (2, n=12) = 6.50, p = .04 (Table 2).
Post hoc analysis with Wilcoxon signed-rank tests was conducted for TNF-α. There were
no significant differences between the middle vs. end time points (Z = -0.275, p = .78). However,
there was a statistically significant reduction in TNF-α levels between the beginning vs. middle
time points (Z = -2.353, p = .02), and between beginning vs. end time points (Z = -1.963, p =
.05). The results of the statistical analysis are shown in Table 2.
There was no observable statistically significant trend with hs-CRP or IL-6. There was a
noted downward trend for IL-6, although not significant. Aside from statistical significance, it is
important to note that the reduction in values was clinically significant. Percent change was
calculated for both hs-CRP and IL-6 to determine if clinical significance was present. There was
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an average increase of 76% for hs-CRP and reduction of 16.3% for IL-6 when comparing the
beginning to the end levels.
A paired-samples t-test was conducted to compare the responses of the SF-36
questionnaire’s eight-areas of quality of life before and after the ginger intervention. The eight
areas tested on the survey included physical functioning, role limitations due to physical health,
role limitations due to emotional problems, energy/fatigue, emotional well-being, social
functioning, pain, and general health. There were no significant differences in the SF-36
questionnaire responses before and after the study with the exception of emotional well-being.
There was a significant increase in the score for emotional well-being post ginger
supplementation (87.3 ± 4.5), compared to pre-ginger supplementation (84.0 ± 6.2), (p = .05).
Results are seen in Table 3.
TABLE 1. MEAN (SD) OF DEMOGRAPHIC CHARACTERISTICS OF STUDY
PARTICIPANTS (n = 12)
Parameter
Value
Female
6
Male
6
Age (years)
42.4 (11.4)
BMI (Kg/m2)
26.4 (4.9)
Exercise (days/week) 3.7 (1.7)
SD: Standard Deviation

TABLE 2. MEAN RANKS OF BLOOD BIOMARKERS (CRP, IL-6, TNF-) OVER
TIME (n = 12)
Biomarker
Mean
Mean Ranks Mean Ranks χ2 df p-value
Ranks
Middle
End
Beginning
CRP
IL-6
TNF-α

1.88
2.25
2.58

2.21
2.17
1.58

1.92
1.58
1.83

1.03
3.30
6.50

2
2
2

.60
.19
.04
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Figure 1. Median and Range of TNF- Concentrations Over Time (n = 12)

Figure 2. Median and Range of IL-6 Concentrations Over Time (n = 12)

Figure 3. Median and Range of hs-CRP Concentrations Over Time (n = 12)
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TABLE 3. PRE AND POST SF-36 MEAN (SD) SCORES BY DOMAIN (n = 12)

Domain

Pre

Post

p-value

Physical Functioning

98.8 (3.1)

97.5 (5.8)

.28

Role limitations d/t physical health

97.9 (7.2)

97.9 (2.2)

1.00

Role limitations d/t emotional prob.

91.7 (28.9)

94.4 (19.3)

.34

Energy/fatigue

68.3 (14.9)

76.0 (14.8)

.12

Emotional well-being

84.0 (6.2)

87.3 (4.5)

.05

Social Functioning

97.9 (7.2)

95.8 (8.1)

.17

Pain
General health

82.9 (18.3)
81.9 (11.5)

85.6 (14.8)
85.8 (13.8)

.47
.12

SD: Standard Deviation

DISCUSSION
The present study was designed to determine if ginger supplementation (3 g/day) has an
effect on lowering inflammation in individuals of varying activity levels. Three blood
biomarkers—TNF-α, IL-6, and CRP—were chosen as indicators of inflammatory status. These
three inflammatory biomarkers have been previously used to asses inflammation levels related to
ginger, exercise, and in chronic diseases such as diabetes and cancer.24-26 Due to ginger’s known
anti-inflammatory phytochemical compounds—gingerols, shogaols, diarylheptanoids,
phenylbutenoids, flavanoids, diterpenoids, sesquiterpenoids, paradols, and zingerone—it was
hypothesized that ginger can potentially be effective at systemic reduction of inflammation in
individuals of varying activity levels.
The results of the eight-week study provided promising results. Tumor Necrosis Factor-α
levels from the start to the end of the study showed statistically significant differences; the
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greatest difference was seen from the beginning and middle time points. Tumor Necrosis Factorα has a variety of roles in the body, and the most notable function for our study is its ability to
recruit inflammatory cells.27 Greater reduction in TNF-α was observed between the beginning
and middle timepoints vs. the middle and end timepoints. This could be due to higher
compliance in daily ginger regimen at the beginning of the study. Although the total compliance
for the entire duration of the study was high (96.2%), there was a 1% reduction in compliance
when comparing the first 4 weeks (96.8%) with the last 4 weeks (95.8%). Another possible
reason we suggest could have been the reduction of TNF-α due to ginger supplementation
stabilized after four weeks. The significant reduction in TNF-α levels in the middle and end
timepoints compared to the beginning timepoint, strengthens the evidence discussed by
Mashhadi et al. and Ricciotti et al. in their respective studies, which suggest that ginger
supplementation can inhibit the inflammatory COX-2 pathway that causes an increase in
undesirable cytokine inflammation and oxidative stress.13,16,19 Toda et. al. (2016) evaluated TNFα in the soleus muscle of physically active mice who consumed black ginger extract for 4 weeks
and found that the mRNA expression levels were lower in the ginger group than in the control
group. This suggests that the anti-inflammatory effects of ginger could benefit one’s health in a
short period of time.28
Interleukin-6 and hs-CRP did not yield statistically significant results. The results of IL-6
levels in our study were consistent with the findings by Mashhadi et al. (2013), which showed
there was an overall reduction in IL-6 levels after ginger consumption, although not statistically
significant.13 A possible explanation could be that the ginger dose and/or duration of
supplementation was insufficient to yield a significant reduction in inflammatory cytokines.
Based on a study by Yimin and Kohanawa (2006), there is a potential negative feedback
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relationship that exists between TNF-α and IL-6.29 Experiments on mice revealed that these
biomarkers have a direct relationship, where the rise in one led to a suppression in the other and
vice versa.29 The exact nature of this relationship and differences in the roles of TNF-α and IL-6
remains to be discovered.29
C-reactive protein levels had the greatest variability throughout the three timepoints. Multiple
factors such as obesity, diet, exercise, smoking, and exposure to environmental toxins play a role
in hs-CRP levels, and could have been possible confounders causing levels to vary throughout
the eight weeks.30 Based on findings from Carpenter et. al, high plasma C-reactive protein
concentrations were significantly correlated with body mass index, lower quality physical health,
fatigue and pain.31 Although 33% of our subjects in our sample met the basal metabolic index
criteria for obesity, most participants were generally healthy adults without major medical
disorders. Furthermore, all participants were recruited from the Loma Linda area, which is
America’s Blue Zone region. Most of the population in this area live longer than other
Americans due to vegetarianism, regular exercise, and omitting smoking and alcohol.
Although not statistically significant, it is of benefit to note the clinical importance of
lowered IL-6 levels throughout the study. With the clinically significant reduction of IL-6, we
suggest ginger can potentially be used as a complementary dietary intervention in managing
inflammatory issues as opposed to the use of medications that often yield more serious side
effects. Interleukin-6 plays an important role to the transition between acute and chronic
inflammation. Within a short period of time, this biomarker is able to destroy the injurious agent
in a localized area while promoting an immune response through local leukocyte recruitment,
death and migration.3 Interleukin-6 is also able to develop specific cellular and humoral immune
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responses, such as end-stage B cell differentiation, immunoglobulin secretion, and T cell
activation.3
Ginger was also shown to increase the levels of self-reported emotional well-being in
individuals. This is important considering that health encompasses not only physical, but also
psychological and emotional well-being.32 Research has established a link between depression
and premature mortality, coronary heart disease, diabetes, and other chronic disorders. 32-34
Positive subjective well-being has been associated as a protective factor for health. 35 Increased
emotional well-being is associated with regular physical activity, increased cardiovascular
health, maintenance of muscle, increased immune regulation, and reduced inflammatory
responses.35-37 High inflammation levels have been associated with a lower quality of life. 38 The
findings of this study suggest that ginger can reduce inflammation levels and increase emotional
health; therefore, ginger can potentially increase quality of life.
There were limitations to our study. Both sample size and short duration of study do not
allow for generalizability to the public and does not speak to long-term effects. Eight weeks may
not be sufficient to observe ginger’s overall effects. Additionally, a larger sample may yield
greater variability in data among individuals of different socioeconomic status and ethnic
background, among others. Secondly, the fact that some of the participants were enrolled during
the holidays is important to take into consideration. The stress of the holidays could have
negatively influenced their inflammatory biomarkers to a greater degree, potentially
overshadowing ginger’s effects. Some of the stressors include lack of sleep, increase in
consumption of refined and high-sugar foods, flu season, decreased activity and exercise, and
greater financial demands.39-41
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Further research is warranted with a larger sample size and longer duration (possibly six
months to a year) to uncover any significant reductions in IL-6 levels, and to establish
appropriate amounts and duration for therapeutic effect. Due to the small sample size,
participants were not evenly distributed among exercise categories. Including individuals with a
wider age and gender range of varying activity levels could increase the generalizability of the
results.
CONCLUSION
The outcome of our study indicates that ginger may be an effective adjuvant treatment
intervention in the management of chronic inflammatory diseases that have become so
widespread in our society. Perhaps the use of ginger as a complement to other medical treatment
modalities can minimize patients’ reliance on medications and lessen the negative side effects
experienced. In addition, ginger may have auxiliary benefits that go beyond improvement in
clinical biomarkers but incorporate other aspects of health that ultimately contribute to whole
person care. Since chronic inflammation has an additive effect over time, older individuals are
more prone to suffering from the drawbacks of living with such conditions, leading to an
increased reliance on medications and decreased physical activity, both of which may be
detrimental to their emotional state. Lowering inflammation can therefore improve quality of
life. Furthermore, the information provided by our research can help educate other healthcare
professionals on the value of nutrition and how specific foods can address certain conditions.
Food can be used as a first step in a treatment plan, rather than an afterthought.

18

19

REFERENCES
1.
2.
3.
4.
5.
6.

7.
8.
9.

10.
11.
12.

13.

14.
15.
16.

17.

18.
19.
20.

Woods JA, Wilund KR, Martin SA, Kistler BM. Exercise, inflammation and aging. Aging
Dis. 2012;3(1):130-140.
Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol
Allergy Clin North Am. 2003;23(1):15-39.
Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8 Suppl 2:S3.
Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of inflammation
in atherosclerosis. J Atheroscler Thromb. 2010;17(1):1-11.
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold
Spring Harb Perspect Biol. 2014;6(10):a016295.
Luna JM, Moon YP, Liu KM, et al. High-sensitivity C-reactive protein and interleukin-6dominant inflammation and ischemic stroke risk: the northern Manhattan study. Stroke.
2014;45(4):979-987.
Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and
infectious diseases. Front Immunol. 2014;5:491.
Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic
inflammation. Clin Chim Acta. 2010;411(11-12):785-793.
Nicklas BJ, Beavers DP, Mihalko SL, Miller GD, Loeser RF, Messier SP. Relationship of
Objectively-Measured Habitual Physical Activity to Chronic Inflammation and Fatigue in
Middle-Aged and Older Adults. J Gerontol A Biol Sci Med Sci. 2016;71(11):1437-1443.
Woods JA, Vieira VJ, Keylock KT. Exercise, inflammation, and innate immunity.
Immunol Allergy Clin North Am. 2009;29(2):381-393.
Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Biochem Soc Trans. 2017;45(5):1105-1115.
Siriwardhana N, Kalupahana NS, Cekanova M, LeMieux M, Greer B, Moustaid-Moussa
N. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr
Biochem. 2013;24(4):613-623.
Mashhadi NS, Ghiasvand R, Askari G, et al. Influence of ginger and cinnamon intake on
inflammation and muscle soreness endued by exercise in Iranian female athletes. Int J
Prev Med. 2013;4(Suppl 1):S11-15.
Sears B, Ricordi C. Anti-inflammatory nutrition as a pharmacological approach to treat
obesity. J Obes. 2011;2011.
Bode AM, Dong Z. The Amazing and Mighty Ginger. In: nd, Benzie IFF, Wachtel-Galor
S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. Boca Raton (FL)2011.
Mashhadi NS, Ghiasvand R, Askari G, Hariri M, Darvishi L, Mofid MR. Anti-oxidative
and anti-inflammatory effects of ginger in health and physical activity: review of current
evidence. Int J Prev Med. 2013;4(Suppl 1):S36-42.
Jolad SD, Lantz RC, Solyom AM, Chen GJ, Bates RB, Timmermann BN. Fresh
organically grown ginger (Zingiber officinale): composition and effects on LPS-induced
PGE2 production. Phytochemistry. 2004;65(13):1937-1954.
Sharifi-Rad M, Varoni EM, Salehi B, et al. Plants of the Genus Zingiber as a Source of
Bioactive Phytochemicals: From Tradition to Pharmacy. Molecules. 2017;22(12).
Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc
Biol. 2011;31(5):986-1000.
Nayebifar S, Afzalpour ME, Kazemi T, Eivary SH, Mogharnasi M. The effect of a 10-

20

21.

22.

23.
24.

25.

26.
27.
28.

29.

30.

31.
32.

33.

34.

35.
36.

37.

week high-intensity interval training and ginger consumption on inflammatory indices
contributing to atherosclerosis in overweight women. J Res Med Sci. 2016;21:116.
Li XH, McGrath KC, Nammi S, Heather AK, Roufogalis BD. Attenuation of liver proinflammatory responses by Zingiber officinale via inhibition of NF-kappa B activation in
high-fat diet-fed rats. Basic Clin Pharmacol Toxicol. 2012;110(3):238-244.
Taleb-Belkadi O, Chaib H, Zemour L, Fatah A, Chafi B, Mekki K. Lipid profile,
inflammation, and oxidative status in peri- and postmenopausal women. Gynecol
Endocrinol. 2016;32(12):982-985.
Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire:
new outcome measure for primary care. BMJ. 1992;305(6846):160-164.
Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of
ginger consumption on glycemic status, lipid profile and some inflammatory markers in
patients with type 2 diabetes mellitus. Int J Food Sci Nutr. 2014;65(4):515-520.
Jones SB, Thomas GA, Hesselsweet SD, Alvarez-Reeves M, Yu H, Irwin ML. Effect of
exercise on markers of inflammation in breast cancer survivors: the Yale exercise and
survivorship study. Cancer Prev Res (Phila). 2013;6(2):109-118.
Wu SH, Shu XO, Chow WH, et al. Nonexercise physical activity and inflammatory and
oxidative stress markers in women. J Womens Health (Larchmt). 2014;23(2):159-167.
Parameswaran N, Patial S. Tumor necrosis factor-alpha signaling in macrophages. Crit
Rev Eukaryot Gene Expr. 2010;20(2):87-103.
Toda K, Hitoe S, Takeda S, Shimoda H. Black ginger extract increases physical fitness
performance and muscular endurance by improving inflammation and energy
metabolism. Heliyon. 2016;2(5):e00115.
Yimin, Kohanawa M. A regulatory effect of the balance between TNF-alpha and IL-6 in
the granulomatous and inflammatory response to Rhodococcus aurantiacus infection in
mice. J Immunol. 2006;177(1):642-650.
Rojo-Martinez G, Soriguer F, Colomo N, et al. Factors determining high-sensitivity Creactive protein values in the Spanish population. Di@bet.es study. Eur J Clin Invest.
2013;43(1):1-10.
Carpenter LL, Gawuga CE, Tyrka AR, Price LH. C-reactive protein, early life stress, and
wellbeing in healthy adults. Acta Psychiatr Scand. 2012;126(6):402-410.
Feller S, Teucher B, Kaaks R, Boeing H, Vigl M. Life satisfaction and risk of chronic
diseases in the European prospective investigation into cancer and nutrition (EPIC)Germany study. PLoS One. 2013;8(8):e73462.
Au B, Smith KJ, Gariepy G, Schmitz N. C-reactive protein, depressive symptoms, and
risk of diabetes: results from the English Longitudinal Study of Ageing (ELSA). J
Psychosom Res. 2014;77(3):180-186.
Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Comprehensive metaanalysis of excess mortality in depression in the general community versus patients with
specific illnesses. Am J Psychiatry. 2014;171(4):453-462.
Steptoe A, Deaton A, Stone AA. Subjective wellbeing, health, and ageing. Lancet.
2015;385(9968):640-648.
Steptoe A, Demakakos P, de Oliveira C, Wardle J. Distinctive biological correlates of
positive psychological well-being in older men and women. Psychosom Med.
2012;74(5):501-508.
Steptoe A, O'Donnell K, Badrick E, Kumari M, Marmot M. Neuroendocrine and

21

38.

39.

40.
41.

inflammatory factors associated with positive affect in healthy men and women: the
Whitehall II study. Am J Epidemiol. 2008;167(1):96-102.
Nowakowski AC. Chronic inflammation and quality of life in older adults: a crosssectional study using biomarkers to predict emotional and relational outcomes. Health
Qual Life Outcomes. 2014;12:141.
Aeberli I, Gerber PA, Hochuli M, et al. Low to moderate sugar-sweetened beverage
consumption impairs glucose and lipid metabolism and promotes inflammation in healthy
young men: a randomized controlled trial. Am J Clin Nutr. 2011;94(2):479-485.
Cheng TO. Seasonal variation in acute myocardial infarction. Int J Cardiol.
2009;135(3):277-279.
Leproult R, Holmback U, Van Cauter E. Circadian misalignment augments markers of
insulin resistance and inflammation, independently of sleep loss. Diabetes.
2014;63(6):1860-1869.

22

Appendix A

23

24

25

26

Appendix B

27

Appendix C

28

